FDA — authorised 11 June 2009
- Application: NDA022348
- Marketing authorisation holder: CUMBERLAND PHARMS
- Status: approved
FDA authorised Caldolor on 11 June 2009
Yes. FDA authorised it on 11 June 2009; FDA has authorised it.
CUMBERLAND PHARMS holds the US marketing authorisation.